Latest From IntriCon Corp.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced October-November 2015.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in November 2015.
Recent executive-level company changes and promotions in the medical device and diagnostics industries.
Recent executive-level company changes and promotions in the biopharma, medical device, and diagnostics industries.
- In Vitro Diagnostics
- Consumables, Central Supplies
- Implantable Devices
- Infusion Therapy Equipment and Supplies
- Monitoring Equipment & Devices
- Therapeutic Areas
- Metabolic Disorders
- Selas Corp. of America
- North America
- Parent & Subsidiaries
- IntriCon Corp.
- Senior Management
Mark S Gorder, Pres. & CEO
Scott J Longval, CFO
Michael P Geraci, VP, Sales & Mktg.
Dennis L Gonsior, VP, Global Operations
- Contact Info
Phone: (651) 636-9770
1260 Red Fox Rd.
Arden Hills, MN 55112
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.